Alkermes ALKS
NASDAQ ALKS
$41.66 +1.12 (+2.76%)
As of: Oct 2, 2026 · 2:06 PM EDT

Alkermes (ALKS) Change in Accured Expenses (2010 - 2026)

Updated

Alkermes (ALKS) reported Change in Accured Expenses of $41.19 million for Q2 2026, down 28.7% from $57.79 million a year earlier.

Analysis

Alkermes (ALKS) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Alkermes' Change in Accured Expenses came in at -$33.5 million; for FY2025, it was $100.89 million.

  • By year, Change in Accured Expenses came in at -$57.97 million in FY2024, $23.01 million in FY2023 (+48.1%), $15.53 million in FY2022 (+34.9%) and $11.51 million in FY2021.
  • Five-year quarterly Change in Accured Expenses spans a low of -$119.47 million in Q1 2026 and a high of $73.03 million in Q4 2025.
  • The high point for year-over-year Change in Accured Expenses in five years was Q2 2023 (growth of 297.6%); the low point was Q3 2023 (a decline of 96.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$119.47 million (Q1 2026), $73.03 million (Q4 2025) and -$28.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.20 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -251.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 901.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 338.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 222.50 Mn
10 Alkermes 6.79 Bn 3.92 Bn 397.90 Mn 41.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.19 Mn
Mar 31, 2026 -119.47 Mn
Dec 31, 2025 73.03 Mn
Sep 30, 2025 -28.25 Mn
Jun 30, 2025 57.79 Mn
Mar 31, 2025 -1.68 Mn
Dec 31, 2024 25.01 Mn
Sep 30, 2024 -81.05 Mn
Jun 30, 2024 36.52 Mn
Mar 31, 2024 -38.45 Mn
Dec 31, 2023 2.05 Mn
Sep 30, 2023 963,000.00
Jun 30, 2023 50.15 Mn
Mar 31, 2023 -30.15 Mn
Dec 31, 2022 9.15 Mn
Sep 30, 2022 27.19 Mn
Jun 30, 2022 12.61 Mn
Mar 31, 2022 -33.41 Mn
Dec 31, 2021 -4.03 Mn
Sep 30, 2021 68.18 Mn
API Access

Alkermes Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ALKS&period=max&api_key=YOUR_API_KEY